Fecal calprotectin concentration in neonatal necrotizing enterocolitis

Korean Journal of Pediatrics

Volumn 57, Issue 8, 2014, Pages 351-356

  Yoon, Jung Min ^a   Park, Ju Yi ^a   Ko, Kyung Ok ^a   Lim, Jae Woo ^a   Cheon, Eun Jeong ^a   Kim, Hyo Jeong ^a  

^a Konyang University College of Medicine   (South Korea)

Author keywords

Calprotectin; Fecal calprotectin; Necrotizing enterocolitis; Premature infant

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; BLOOD GAS ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ELISA KIT; FECES ANALYSIS; GESTATIONAL AGE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; NECROTIZING ENTEROCOLITIS; NEWBORN; NON INVASIVE PROCEDURE; PREMATURITY; PROTEIN ANALYSIS; THROMBOCYTE COUNT;

EID: 84925829752     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2014.57.8.351     Document Type: Article

References (27)

1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255-264.
2. Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010;251:1174-1180.
3. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, et al. Functional and clinical aspects of the myelo-monocyte protein calprotectin. Mol Pathol 1997;50:113-123.
4. Røseth AG, Fagerhol MK, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-798.
5. Tøn H, Brandsnes F, Dale S, Holtlund J, Skuibina E, Schjonsby H, et al. Improved assay for fecal calprotectin. Clin Chim Acta 2000; 292:41-54.
6. Kristinsson J, Roseth A, Fagerhol MK, Aadland E, Schjonsby H, Bormer OP, et al. Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum 1998;41:316-321.
7. Berstad A, Arslan G, Folvik G. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand J Gastroenterol 2000;35:64-69.
8. Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997;58:176-180.
9. Meling TR, Aabakken L, Roseth A, Osnes M. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-infammatory drugs. Scand J Gastroenterol 1996;31:339-344.
10. Røseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with infammatory bowel disease. Scand J Gastroenterol 1999;34:50-54.
11. Aadland E, Fagerhol MK. Faecal calprotectin: a marker of infam-mation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002;14:823-825.
12. Golden BE, Clohessy PA, Russell G, Fagerhol MK. Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child 1996;74:136-139.
13. Burri E, Beglinger C. Faecal calprotectin: a useful tool in the mana gement of inflammatory bowel disease. Swiss Med Wkly 2012;142:w13557.
14. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Infamm Bowel Dis 2006;12:524-534.
15. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201.
16. Reisinger KW, Van der Zee DC, Brouwers HA, Kramer BW, van Heurn LW, Buurman WA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg 2012;47:1640-1645.
17. Klip H, Burger CW, de Kraker J, van Leeuwen FE; OMEGA-project group. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod 2001;16:2451-2458.
18. Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002;91:45-50.
19. Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, et al. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 2004; 36:467-470.
20. Carroll D, Corfield A, Spicer R, Cairns P. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet 2003;361:310-311.
21. Aydemir O, Aydemir C, Sarikabadayi YU, Emre Canpolat F, Erdeve O, Biyikli Z, et al. Fecal calprotectin levels are increased in infants with necrotizing enterocolitis. J Matern Fetal Neonatal Med 2012; 25:2237-2241.
22. Shulman RJ, Ou CN, Smith EO. Evaluation of potential factors predic ting attainment of full gavage feedings in preterm infants. Neonatology 2011;99:38-44.
23. Josefsson S, Bunn SK, Domellof M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007;44:407-413.
24. Rouge C, Butel MJ, Piloquet H, Ferraris L, Legrand A, Vodovar M, et al. Fecal calprotectin excretion in preterm infants during the neonatal period. PLoS One 2010;5:e11083.
25. Hällström M, Koivisto AM, Janas M, Tammela O. Laboratory parameters predictive of developing necrotizing enterocolitis in infants born before 33 weeks of gestation. J Pediatr Surg 2006; 41:792-798.
26. Pourcyrous M, Korones SB, Yang W, Boulden TF, Bada HS. C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics 2005;116:1064-1069.
27. Isaacs D, North J, Lindsell D, Wilkinson AR. Serum acute phase reactants in necrotizing enterocolitis. Acta Paediatr Scand 1987; 76:923-927.